Condition: Allergic Asthma · Sponsor: Oneness Biotech Co., Ltd.
This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.
This description comes directly from the study's public registry record.
June Kuo · +886 2 2703 1098 · June.Kuo@onenessbio.com.tw
Pei-Jin Ho · +886 2 2703 1098 · Peijin.Ho@onenessbio.com.tw
Always discuss trial participation with your own doctor first.
| Kaohsiung Chang Gung Medical Foundation | Kaohsiung City, Taiwan | Recruiting |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung City, Taiwan | Recruiting |
| Far Eastern Memorial Hospital | New Taipei City, Taiwan | Recruiting |
| China Medical University Hospital | Taichung, Taiwan | Recruiting |
| Taichung Venterans General Hospital | Taichung, Taiwan | Recruiting |
| National Cheng Kung University Hospital | Tainan, Taiwan | Recruiting |
| Linkou Chang Gung Memorial Hospital | Taipei, Taiwan | Recruiting |
| MacKay Memorial Hospital | Taipei, Taiwan | Recruiting |
| Ministry of Health and Welfare Shuang-Ho Hospital | Taipei, Taiwan | Recruiting |
| National Taiwan University Hospital | Taipei, Taiwan | Recruiting |
| Taipei Medical University Hospital | Taipei, Taiwan | Recruiting |
| Taipei Municipal Wanfang Hospital | Taipei, Taiwan | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05008965